Stock 6620 HANDA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Handa Pharmaceuticals, Inc.

Equities

6620

TW0006620008

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
137 TWD -2.49% Intraday chart for Handa Pharmaceuticals, Inc. +10.04% -25.34%
04-02 Handa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Handa Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • Based on current prices, the company has particularly high valuation levels.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
HANDA PHARMACEUTICALS, INC. Stock Handa Pharmaceuticals, Inc.
-25.34% 597M -
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.09% 44.4B
B-
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+24.60% 23.03B
B+
SANDOZ GROUP AG Stock Sandoz Group AG
+17.29% 15.14B -
CIPLA LIMITED Stock Cipla Limited
+12.97% 13.12B
B+
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.52% 11.85B
B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.33% 6.99B
B+
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B - -
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B - -
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.22% 5.52B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
-
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 6620 Stock
  4. Ratings Handa Pharmaceuticals, Inc.